(Reuters) - The U.S. Food and Drug Administration on Friday said it plans to let medical device makers report less serious malfunctions of some devices on a quarterly basis to cut down on repeated reviews of common problems. The FDA said in a statement that it is proposing...
(Reuters) - Canadian drugmaker Valeant Pharmaceuticals International Inc said the U.S. Food and Drug Administration approved Lumify drop to treat eye redness. The eye drop, made by the company’s Bausch & Lomb eye care business, has been approved for over-the-counter sale, Valeant said. Lumify, first approved...
(Reuters) - Ocular Therapeutix Inc said on Friday the U.S. Securities and Exchange Commission (SEC) had issued a subpoena seeking information about the company’s eye-pain drug Dextenza. Shares of the company were down 7.2 percent at $4.25 in after-marketing trading. The subpoena included a request to furnish Dextenza-related...
(Reuters Health) - People who take a certain water pill prescribed to control fluid retention and treat high blood pressure may be more likely to get skin cancer than other individuals, a Danish study suggests. While the drug, hydrochlorothiazide, has long been linked to an increased risk...
(Reuters Health) - With the same health insurance and access to the same medical providers, black trauma patients may be no more likely to die than their white counterparts, a U.S. study suggests. Even though all U.S. hospitals are required to treat trauma patients regardless of their...
(Reuters) - A U.S. judge on Friday overturned a $150 million verdict against AbbVie Inc that was first to result from lawsuits claiming that the company fraudulently misrepresented the risks of its testosterone replacement drug AndroGel. U.S. District Judge Matthew Kennelly in Chicago ruled that the...
(Reuters Health) - Light massage can reduce pain, anxiety and the need for opioid medication in terminally ill patients, a Swedish study suggests. “All end-of-life patients experience existential pain or existential suffering,” coauthor Linda Bjorkhem-Bergman told Reuters Health. “This pain is difficult to treat pharmacologically and complementary...
